Publication | Closed Access

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor

VaccinationCell TherapyImmunologyTherapeutic VaccineAutomated BioreactorBiological TherapyAdoptive ImmunotherapyBiomedical EngineeringImmunotherapyMedicineCell TransplantationNatural Killer CellsFeeder-free Expansion